Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AGOX | 25.66 | 2.38 | +10.22% |
| Adaptive Alpha Opportunities ETF | |||
| SQLV | 35.85 | 2.48 | +7.43% |
| Royce Quant Small-Cap Quality Value ETF | |||
| VSS | 110.99 | 6.76 | +6.49% |
| Vanguard FTSE All-Wld ex-US SmCp ETF | |||
| RAAX | 28.73 | 1.54 | +5.68% |
| VanEck Real Assets ETF | |||
| UYLD | 51.09 | 0.02 | +0.03% |
| Angel Oak UltraShort Income ETF | |||
A.I.dvisor indicates that over the last year, KMSTF has been loosely correlated with IRON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KMSTF jumps, then IRON could also see price increases.
| Ticker / NAME | Correlation To KMSTF | 1D Price Change % | ||
|---|---|---|---|---|
| KMSTF | 100% | N/A | ||
| IRON - KMSTF | 54% Loosely correlated | +12.89% | ||
| ATBPF - KMSTF | 52% Loosely correlated | N/A | ||
| ZVRA - KMSTF | 30% Poorly correlated | +3.79% | ||
| ACUT - KMSTF | 28% Poorly correlated | -27.26% | ||
| SRZN - KMSTF | 28% Poorly correlated | +0.59% | ||
More | ||||